Skip to main content
Fig. 3 | Respiratory Research

Fig. 3

From: Efficacy of umeclidinium/vilanterol according to the degree of reversibility of airflow limitation at screening: a post hoc analysis of the EMAX trial

Fig. 3

Improvement in SAC-TDI focal score at Week 24. Vertical dotted lines indicate quintiles of reversibility at baseline. The MCID of SAC-TDI score is ≥ 1-point improvement from baseline [13]. BDI, Baseline Dyspnoea Index; CI, confidence interval; FEV1, forced expiratory volume in 1 s; FP, fractional polynomial; LS, least squares; MCID, minimal clinically important difference; SAC-TDI, self-administered computerised-Transition Dyspnoea Index; SAL, salmeterol; UMEC, umeclidinium; VI, vilanterol

Back to article page

Respiratory Research

ISSN: 1465-993X

Contact us